Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Tesla
TSLA
|
+$877M |
| 2 |
Marvell Technology
MRVL
|
+$723M |
| 3 |
KKR & Co
KKR
|
+$502M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$393M |
| 5 |
SW
Smurfit Westrock plc
SW
|
+$380M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.45B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.15B |
| 3 |
Apple
AAPL
|
+$592M |
| 4 |
Charles Schwab
SCHW
|
+$491M |
| 5 |
Amazon
AMZN
|
+$438M |
Sector Composition
| 1 | Technology | 31.86% |
| 2 | Financials | 12.66% |
| 3 | Consumer Discretionary | 11.93% |
| 4 | Healthcare | 9.58% |
| 5 | Communication Services | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RWT
2326
Redwood Trust
RWT
$802M
| $2.13M | ﹤0.01% |
326,700
| – | – |
|
2327
FIGS
FIGS
$1.11B
| $2.13M | ﹤0.01% |
344,615
-1,375,164
| -80% | -$8.51M |
|
2328
Adaptive Biotechnologies
ADPT
$1.89B
| $2.13M | ﹤0.01% |
354,842
| – | – |
|
2329
iShares Russell 2000 Value ETF
IWN
$12B
| $2.11M | ﹤0.01% |
+12,880
| New | +$2.11M |
|
2330
Rocket Pharmaceuticals
RCKT
$343M
| $2.11M | ﹤0.01% |
167,716
| – | – |
|
2331
Prothena Corp
PRTA
$447M
| $2.11M | ﹤0.01% |
152,107
+381
| +0.3% | +$5.28K |
|
2332
Opko Health
OPK
$1.12B
| $2.11M | ﹤0.01% |
1,432,404
+425,484
| +42% | +$625K |
|
2333
Axogen
AXGN
$739M
| $2.09M | ﹤0.01% |
127,076
-21,370
| -14% | -$352K |
|
2334
BioLife Solutions
BLFS
$1.27B
| $2.08M | ﹤0.01% |
80,160
| – | – |
|
2335
Rush Enterprises Class B
RUSHB
$4.4B
| $2.08M | ﹤0.01% |
38,145
+445
| +1% | +$24.2K |
|
2336
Enhabit
EHAB
$409M
| $2.07M | ﹤0.01% |
265,361
+129,610
| +95% | +$1.01M |
|
2337
Snap
SNAP
$12.3B
| $2.07M | ﹤0.01% |
192,312
-320,750
| -63% | -$3.45M |
|
2338
BrightView Holdings
BV
$1.31B
| $2.07M | ﹤0.01% |
129,172
-389,220
| -75% | -$6.22M |
|
2339
Jack in the Box
JACK
$342M
| $2.06M | ﹤0.01% |
49,543
-462
| -0.9% | -$19.2K |
|
2340
ATS Corp
ATS
$2.58B
| $2.06M | ﹤0.01% |
67,643
| – | – |
|
2341
Cytek Biosciences
CTKB
$476M
| $2.06M | ﹤0.01% |
317,301
| – | – |
|
2342
Domo
DOMO
$643M
| $2.05M | ﹤0.01% |
289,863
-101,920
| -26% | -$722K |
|
2343
Hovnanian Enterprises
HOV
$869M
| $2.05M | ﹤0.01% |
15,331
| – | – |
|
2344
Telos
TLS
$505M
| $2.05M | ﹤0.01% |
599,868
-7,210
| -1% | -$24.7K |
|
2345
LifeMD
LFMD
$279M
| $2.05M | ﹤0.01% |
413,501
+129,470
| +46% | +$641K |
|
2346
Sturm, Ruger & Co
RGR
$587M
| $2.05M | ﹤0.01% |
57,837
| – | – |
|
2347
Avanos Medical
AVNS
$576M
| $2.04M | ﹤0.01% |
128,365
| – | – |
|
|
RC
2348
Ready Capital
RC
$675M
| $2.01M | ﹤0.01% |
294,289
| – | – |
|
2349
CVRx
CVRX
$205M
| $2.01M | ﹤0.01% |
158,399
-51,730
| -25% | -$655K |
|
2350
First Mid Bancshares
FMBH
$954M
| $2.01M | ﹤0.01% |
54,480
+3,830
| +8% | +$141K |
|